Synopsis of Proposed Contract Action number W911SR-11-S-0001

Subject: VRP Intellectual Property License

The U.S. Army Research Development, and Engineering Command on behalf of
the Chemical Biological Medical Systems Joint Vaccine Acquisition Program
(CBMS-JVAP) intends to procure on a sole source basis an exclusive, perpetual
license to the Intellectual Property to Alphavaxs proprietary Venezuelan Equine
Encephalitis (VEE)- based RNA replicon/helper particle system for the field of
filovirus vaccines. The intended contractor is AlphaVax, Inc., Research Triangle
Park, North Carolina, 27709.

It is anticipated that a Firm Fixed Price type contract will be issued for the
purchase of an exclusive license to the intellectual property that has improved
the existing U.S. Government owned VEE-replicon particle technology (GVRP
Technology). AlphaVax, Inc. is the only known source that has built upon the
existing GVRP Technology. The contract will include (i) one base CLIN for the
AlphaVax patents owned or to which AlphaVax has an exclusive license needed
to develop and produce a filovirus vaccine and (ii) an option CLIN for specific
AlphaVax Know-How. The NAICS Code associated with the planned
procurement is 541711.

The proposed solicitation number is W911SR-11-R-0003.

The statutory authority permitting acquisition of this requirement by other than full
and open competition is 10 U.S.C. 2304(c)(1), as implemented by FAR 6.302-
1(a)(2)(iii) Only One Responsible Source and No Other Supplies or Services will
Satisfy Agency Requirements.

While this notice is not a request for competitive proposals, responsible parties
purporting to have the requisite intellectual property to this technology who can
provide the patents without unacceptable delays or expense in fulfilling the
agencys requirements must furnish, in writing within 15 days of this notice,
factual information which clearly supports and demonstrates that their company
is sufficiently able to provide an exclusive license to the modified VEE-replicon
particle technology developed by the U.S. Government as described in patent
5,792,462.

The Contracting Officer responsible for this action is Mr. Lawrence Mize. A
determination not to compete this proposed action based on any responses to
this notice is solely within the discretion of the Contracting Officer. Please direct
any questions regarding this announcement to Mr. Lawrence Mize, by email at
[email protected] within 15 days of this notice.

Contracting Office Address:
Mr. Lawrence Mize
RDECOM-Natick
64 Thomas Johnson Drive
Frederick, MD 21702-4300

Bid Protests Not Available